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Leishmania species cause a spectrum of illness that ranges from asymptomatic
seroconversion toprogressive and ultimately fatal infection. Although many manifesta-
tions ofthis disease are due to differences amongthe Leishmania species themselves,
host factors are clearly important in determining whetherinfection is controlled or
allowed to progress inexorably (1).
Murine infectionwith Leishmania majormimics humaninfection due to L. donovani.
Both self-limited and progressive visceral infections occur; thelatter is accompanied
by hepatosplenomegaly, anemia, and hypergammaglobulinemia. Among inbred
mouse strains, non-MHC II-linkedgenetic susceptibilityto dissemination hasbeen
well characterized. Although both C57BL/6 and BALB/c mice are susceptible to
infection with L. major, C57BL/6 mice resolve infection with the establishment of
lasting immunity, whereas BALB/c mice fail to control local replication ofthe para-
site and suffer fatal progressive disease. In C57BL/6 mice, the ability to control in-
fection has been linked directly to parasite-specific Th by various cell transfer and
depletion experiments (2, 3); neither Lyt-2+ Tcells (4) nor NK cells (5) are crit-
ical forresolution ofinfection. C57BL/6 mice healconcomitant with the appearance
ofmRNA for IFN-y in the lymphoid organs of infected animals (6), together with
the ability oflymphocytes to generate IFN-yafter stimulation with Leishmania an-
tigens in vitro (7). Neither occurs amongnonhealer BALB/c mice with progressive
disease. Experiments examiningIFN-yproduction in vitro among infected orhealing
human patients have reporteda similarassociation (8, 9). Evidence to date suggests
that IFN-y is a critical macrophage-activating factor mediating cellular defense
against the obligate intracellular amastigote (10, 11).
The ability ofBALB/c lymphocytes to respond to infection by generating IFN-y
is not due to a failure ofL3T4+ cells to proliferate; in fact, these cells expand more
rapidly in infected BALB/c mice than in healer strains (12-14). Recent studies have
documented two subsets ofhelper L3T4+ T cells among murine T cell clones (15).
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The presence of these subsets has been established in vivo (16, 17). To date, no sur-
face antigens have been identified that distinguish these two subsets, and their dis-
tinction depends upon the unique lymphokine profiles generated by these cells in
response to antigens and mitogens. IFN-y is uniquely secreted by one subset, desig-
nated Thl, that has been demonstrated to mediate delayed-type hypersensitivity (18).
The othersubset, designated Th2, uniquely releases several B cell growth and stimula-
tory factors, including IL-4 and IL-5 (19). Our finding that resolution of murine
leishmaniasis was associated with the production of IFN-y prompted us to examine
the hypothesis that progression of disease concomitant with L3T4+ cell expansion
was consistant with Th2 cell proliferation and would be associated with the produc-
tion of IL-4 in the same lymphoid tissues. We demonstrate here that IFN-y and
IL-4 are produced reciprocally in resolving or progressive infection in murine leish-
maniasis, consistent with the hypothesis that distinct Th subsets moderate the spec-
trum ofthis infectious disease. Further, passive administration of a neutralizing anti-
IL-4 mAb attenuated the progression of Leishmania infection in susceptible mice,
suggesting that activities mediated by this lymphokine favor the progression of in-
fection.
Materials and Methods
Special Reagents.
￿
Rat mAbs were partially purified by ammonium sulfate precipitation
from ascites produced by the hybridomas GK1.5 (anti-L3T4, IgG2b; American Type Cul-
ture Collection, Rockville, MD) (20), 11B11 (antimurine IL-4; IgGl; kindly provided by Dr.
T. R. Mosmann, DNAX Research Institute, Palo Alto, CA) (21), and R4-6A2 (antimurine
IFN-y, IgG1;.American Type Culture Collection) (22). Both the 111311 and R4-6A2 hybrid-
omas produce neutralizing antibodies. Plasmids containing specific cDNA were gifts from
the following individuals: murine IFN-y (550-bp Eco RI-Eco RV fragment), Dr. P. W. Gray,
Genentech, Inc., South San Francisco, CA (23); IL-2 (330-bp Pst I-Hind III) and IL-4 (370
by Pstl), Dr. T. Yokota, DNAXResearch Institute, Palo Alto, CA (24, 25), and p-Actin (2,000-
bp Pst I), Dr. D. W. Cleveland, Princeton University, Princeton, NJ (26). Plasmid prepara-
tion, restriction digests, and fragment isolation from low-melting point agarose gel were per-
formed as described (27). Dr. R. Devos (Biogent, Ghent, Belgium) provided murine IL-4
cDNA subcloned into pGEM-I (Promega Corp., Madison, WI) that was used for the prepa-
ration of the IL-4 RNA probe. An oligonucleotide probe complementary to the DNA se-
quence encoding residues 207-220 (28) of murine IL-ID (TGT TGA AGA CAA ATC GCT
TTT CCA TCT TCT TCT TTG GGT A) was obtained from the Biomolecular Resource
Center at UCSF Medical Center.
Parasites.
￿
L. major promastigotes (World Health Organization strain WHOM/IR/-/173)
were propagatedin M199 medium (Gibco Laboratories, Grand Island, NY) containing 30%
FCS (Sterile Systems, Logan, UT) penicillin G (100 U/ml), streptomycin (100 mg/ml), and
amphotericin B (40 mg/ml), as described (7). Promastigotes were harvested from stationary-
phase culture by centrifugation, washed, and enumerated microscopically after immobiliza-
tion of an aliquot in 30% ethanol/20% glycerol in PBS, pH 7.2, before use.
Mice.
￿
Female 8-10-wk-old BALB/c and C57BL/6 mice were purchased from TheJackson
Laboratory(Bar Harbor, ME) and housed in the animal care facility at UCSF Medical Center.
Mice were inoculated in each hind footpad with 5 x 106 promastigotes in HBSS. In selected
experiments, BALB/c mice were pretreated with 1 mg of GK1 .5 anti-L3T4-mAb i.p. 18 h
before infection as described (6). Designated mice were treated with 0.5 mg of either 111311
anti-IL-4 or R4-6A2 anti-IFN-y mAb i.p. at the time of infection and weekly thereafter.
Sample Tissues and Cells.
￿
Uninfected and infected animals (3, 4, 6, and 8 wk of infection)
were euthanized, the excised spleens and draining lymph nodes were minced against a No.
100 steel mesh screen, and the suspended cells were washed in RPMI 1640 medium (Irvine
Scientific, SantaAna, CA). Erythrocytes were lysed usingtris-buffered ammonium chlorideHEINZEL ET AL.
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and the cells were washed twice in 0 .15 M sodium chloride, 15 mM sodium citrate buffer,
pH 7.2 (SSC), that had been pretreated with diethylcarbonate (DEPC, Sigma Chemical Co.,
St. Louis, MO). Blood was collected from the tail veins of infected and uninfected BALB/c
and C57BL/6 mice, and the prepared serum was stored at -20°C before use.
Quantitation of Tissue Parasites.
￿
At designated periods afterinfection, the footpad thickness
was measured usingcalipers to assess the progression of the localinfection (14). The footpads
were removed, soaked in alcohol, allowed to dry, crushed against a steel screen using a plastic
syringe barrel, and strained through a No. 100 mesh screen to remove large debris. The draining
popliteal lymph nodes were excised, minced, and strained into separate single cell suspen-
sions in HBSS through a steel mesh screen. Cell suspensions were washed, treated with tris-
buffered ammonium chloride, pH 7 .5, to lyse erythrocytes, rewashed, and brought to 10 ml
(footpad suspensions) or 1 ml (lymph node suspensions) volumes in HBSS. The numbers
of viable tissue parasites were established by culture of dilutions of these cell suspensions
in vitro for 3 d at 27°C to allow conversion of amastigotes to the motile promastigote forms
under conditions that do not support the viability of host cells. Detection ofviable organisms
was accomplished both by direct microscopic observation and by a modification ofthe tetrazo-
lium reduction assay used for mammalian cells as previously described (29). In brief, 100-111
aliquots of the tissue suspensions were distributed to 900 wl of M199 containing antibiotics
and 30% heat-inactivated FCS and subsequently subjected to six serial 10-fold dilutions. The
finaldilutions of the footpad tissue ranged from 103 to 108 , and of the lymph nodes, 102-107.
Aliquots of 100 ul from each dilution tube were transferred in quadruplicate samples to 96-
well microtiter trays and incubated at 27°C in 5% C02 air. After 72 h the numbers of sur-
viving and/or proliferating promastigotes were quantitated by colorimetric reduction of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT; Sigma Chemical Co.)
as described (29). Briefly, 50 wg MTT was added to each well for 4 h, 80 Al of 0.05 M HCl
in isopropanol was added to dissolve the blue formazan crystals, and the color was quanti-
tated at 560 nm using a Microelisa plate scanner (BioTek Instruments, Inc.; Burlington,
VT) against a reference wavelength of 690 nm.
Isolation of RNA.
￿
Poly-A' mRNA was purified from cell preparations using guanidine
HCl lysis (30) and oligo-dT-affinity chromotography (31), subjected to electrophoresis in
formaldehyde-denatured, IO/o agarose gel (5 or 10 wg/lane), stained with ethidium bromide,
photographed, and transferred to nylon membranes (Amersham Corp., Arlington Heights,
IL) usingcapillary blotting. Ethidium bromide staining was used to confirm that comparable
quantities of RNA were present in each lane.
Preparation ofLabeled Probes.
￿
Cytokine-specific cDNA fragments were labeled to a specific
activity of 1-2 x 108 cpm/Ilg using a- nick-translation kit (Bethesda Research Laboratories,
Gaithersburg, MD) and "P-a-dCTP sp act, 800 Ci/mmole, New England Nuclear, Boston,
MA) (27). Antisense RNA probes were produced using an SP6 RNA polymerasekit (Promega
Biotec, Madison, WI) and 32P-a-CTP (3,000 Ci/mmol, New England Nuclear). Oligonu-
cleotide probes were end-labeled to a sp act of 2-5 x 109 cpm/wg using T4 polynucleotide
kinase (International Biotechnology Inc., New Haven, CT) and 32p-y-ATP (3,000 mCi/mol,
New England Nuclear) (27).
Northern Hybridizations.
￿
For use with cDNA probes, membranes were preincubated over-
night at 42°C in prehybridization solution (50% formamide, 0.1% Ficoll, 0.1% polyvinyl-
pyrrolidone, 0.1% BSA, 1.5 M NaCl, 25 mM phosphate buffer, pH 7 .4, 1 mg/ml yeast RNA,
and 200 mg/ml denatured salmon sperm DNA) and then further incubated with 5 x 106
cpm of nick-translated probe at 42 °C for 18 h in prehybridization solution containing 10%
dextran. The blots were washed using high-stringency conditions (0.2 x SSC, 0.1% SDS
at 55'C) and exposed to x-ray film (XAR5, Eastman Kodak Co., Chester, NY) with in-
tensification screens at -70°C . Membranes hybridized with oligonucleotide probes were prein-
cubated in 0.2% polyvinyl-pyrrolidone, 0.2% Ficoll, 0.2% BSA, 150 wg/ml salmon sperm
DNA, 1.7 mg/ml yeast RNA, 2 x SSG overnight at room temperature, and then further in-
cubated with 5 x 106 cpm of probe in the same buffer at 57°C. The membranes were then
washed in 2 x SSC for 1 h at 50°C . In indicated experiments, 32P-labeled antisense RNA
probe was used to detect IL-4 mRNA using hybridization techniques similar those used for
nick-translated probes, but with incubations and washes performed at 65°C and a final incu-62
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bation with 20 gg/ml of RNase A (Sigma Chemical Co.) to remove nonspecifically bound
probe (27) . The intensity ofhybridization was analyzed by laser densitometry(LKB; Bromma,
Sweden) . After autoradiography, the membranes were washed in 20mM Tris/0.1% SDS/10
mM EDTA at 85°C for 90 min to remove hybridized probe .
Serum IgE Determinations .
￿
Serum was assayed for IgE using a solid-phase ELISA tech-
nique . A double-sandwich assay using rabbit antimurine IgE antiserum, and a rat mAb specific
for mouse IgE (EM95) was used as described (32) .
Results
Groups of healer C57BL/6 and nonhealer BALB/c mice were infected withL . major
in the footpads, and the draining lymph nodes and spleen were harvested at 3, 4,
6, and 8 wk after inoculation . Previous studies have established that infection under
these conditions causes comparable local infection for the first 3 wk, but thereafter,
infection in the C57BL/6 mice is eliminated whereas infection progresses to footpad
ulceration and visceral dissemination to the spleen and liver in the BALB/c by 8 wk
of infection (7) . The lymphoid cells were immediately disrupted, the mRNA was
extracted, and the poly(A)+ RNA was purified and subjected to electrophoresis be-
fore sequential hybridizations with selected cDNA probes (Fig . 1). In healer C57BL/6
mice, mRNA for IFN-y was present in spleen by 3 wk of infection, and was con-
tinuously expressed over the subsequent 8 wk . Message for IFN-y was present in
the draining lymph nodes at all times (not shown) and continued to be heavily ex-
pressed at 8wk . In contrast, in the BALB/c mice,mRNA for IFN-y was not present
in spleen until 4 wk, peaked at 6 wk, and subsequently disappeared ; IFN-ymRNA
was not present in the lymph node cell populations . Message for IFN-y was not
FIGURE 1 . Cytokine mRNA
during leishmaniasis . Poly(A)'
RNA (5 Wg) was isolated from
the spleens andlymph nodes of
BALB/c (B) and C57BL/6 (C)
mice at designated times after
infection with L. major . North-
ern hybridizations were per-
formed using the indicated
cytokine-specific probes (see
Materials and Methods) . Con-
trol RNA is from uninfected
BALB/c spleen .HEINZEL ET AL.
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present in normal C57BL/6 or BALB/c splenic tissue. The presence ofmRNA corre-
lates with previous measurements of IFN-y protein produced after stimulation of
these lymphocyte populations with leishmania antigens in vitro (6, 7).
Rehybridization ofthe same blots with an IL-2 cDNA probe revealed that, at most
periods after infection, comparable levels of message for this lymphokine were pro-
duced. Although resting C57BL/6 spleen had relatively low levels of IL-2 message
(not shown), resting BALB/c splenic tissue contained detectable IL-2 mRNA .
Rehybridization using an IL-4 cDNA revealed significant differences as compared
with IFN-y . Thus, IL-4 expression was present at 4, 6, and 8 wk in BALB/c spleen,
and at 8 wk in BALB/c lymph node cells, but was not present in C57BL/6 cell prepa-
rations. IL-4 message was not present in spleen from either mouse strain under resting
conditions.
Recent reports have suggested that the T cell growth factor activity of IL-4 re-
quires IL-1 as an accessory growth factor for Th2 cells (33). When the Northern
blots were rehybridized using a labeled cDNA for murine IL-1, IL-1 message was
substantially more expressed in tissues from infected BALB/c as compared with
C57BL/6 mice (Fig. 1). Although expressed at low levels in normal BALB/c spleen,
mRNA for IL-1 was increased 10-20-fold in lymphoid tissues from BALB/c mice
at all times during the course of Leishmania infection.
Finally, the blots were assayed using ethidium bromide fluorescence at the begin-
ning of the assay (not shown) and ß-actin hybridization at the end of the sequential
hybridizations to confirm that comparable poly(A)+ RNA had been analyzed in
each lane (Fig. 1).
BALB/c mice that have been pretreated with mAb GK1.5 to deplete L3T4+ cells
at the time of infection heal Leishmania infection (6, 34). To ascertain that species
differences did not account for the previous discrepant findings, sequential cytokine
hybridizations were repeated using tissues harvested from infected BALB/c mice
and from infected BALB/c mice that had been pretreated with GK1.5 antibody. Tissues
were harvested at 8 wk at a time when L3T4+ T cells have repopulated the lym-
phoid tissues of GK1.5-treated mice (6). A group of C57BL/6 mice were coinfected
and assayed concurrently. The final hybridization utilized an IL-4 antisense RNA
probe followed by RNase digestion to improve the sensitivity of IL-4 detection. As
previously demonstrated, infected C57BL/6 mice demonstrated message for IFN-y
and IL-2 in spleen but no message for IL-4 (Fig. 2 A). Conversely, BALB/c demon-
strated message for IL-2 and IL-4, but little message (20-fold less) for IFN-y . Fi-
nally, BALB/c that had been pretreated with GK1.5 demonstrated tissue expression
ofIFN-y and IL-2, but not IL-4. The draining lymph node tissues from the BALB/c,
but not from the GK1.5-pretreated BALB/c, expressed readily detectable IL-4 mes-
sage (Fig. 2 B). Message for IL-4 (and IFN-y) was consistently more heavily ex-
pressed in lymph node than in splenic tissues (Figs. 1 and 2), presumably reflecting
the ascending nature ofthe infection from the footpads, to the draining lymph nodes,
and thence to the spleen (6).
To assess IL-4 biologic activity in vivo, serum IgE levels were quantitated in
C57BL/6, BALB/c, and GK1.5-pretreated BALB/c mice before and after 8 wk of
infection (Table I). Serum levels in infected BALB/c mice, but not in control, C57BL/
6-, or GK1.5-pretreated mice, were significantly elevated, and were comparable with
levels reported after nematode infection in BALB/c mice (35).64
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FIGURE 2 .
￿
LymphokinemRNA generation after tran-
sient in vivo depletion of L3T4' cells . (A) Poly(A)'
RNA (10 lig/lane) was isolated from the spleens of
C57BL/6 (C), BALB/c (B) and GK1 .5-pretreated
BALB/c mice (G) after 8 wk ofinfection and hybridized
with the indicated cDNA probes . To increase sensitivity,
IL-4 mRNA was detected using 32P-labeled antisense
RNA and was followed with RNase digestion to remove
unbound probe . (B) Poly(A)' RNA (10 jig) was ob-
tained from the draining nodes ofinfected BALB/c (B)
and GK1.5-pretreated BALB/c mice (G) after 8 wk of
infection and hybridized with IL-4-specific antisense
RNA.
The presence of IL-4mRNA in lymphoid tissues during progression of infection,
together with the prior demonstration of L3T4' cell expansion during the course
of disease (12-14), suggested that these L3T4' cells might represent Th2 cells that
have previously been defined at the clonal level (15) . In an attempt to interfere with
TABLE I
Effect of L . major Infection on Serum IgE Levels in Normal and
GK1.5-pretreated Mice
Groups of three BALB/c, mAb GK1.5-pretreated BALB/c, or C57BL/6 mice
were infected with L . major, and the sera were collected both immediately (0 wk)
and after 6 wk of infection before being assayed for IgE (see Materials and
Methods) .
Mouse strain
GK1 .5
Pretreatment
Duration of
infection
wk
Serum
uglml
IgE level
t SD
BALB/c - 0 0.22 ± 0.11
BALB/c - 6 28.55 ± 7.48
BALB/c + 0 0.10 ± 0.02
BALB/c + 6 1 .24 ± 1 .68
C57BL/6 - 0 <0.10 ± ND
C57BL/6 - 6 <0.10 t NDHEINZEL ET AL .
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IL-4-mediated functions in vivo, we administered neutralizing anti-IL-4 mAb to
susceptible BALB/c mice and monitored the course of subsequent Leishmania in-
fection . As assessed by thickness of the primary lesion at 5 and 8 wk (Fig. 3) and
by direct quantitation of parasites in the footpads and lymph nodes (Table II), anti-
IL-4 significantly attenuated the progression ofleishmaniasis in susceptible BALB/c
mice . Protection against tissue swelling and ulcerationwas most significant at 5 wk,
and was associated with a 5-log reduction in the numbers of recoverable tissue para-
sites from the primary (footpad) lesions . Serum IgE concentrations were reduced
from 8.8 ± 2 .1 wg/ml in the infected BALB/c to 0.4 ± 0.2 wg/ml in infected BALB/c
mice that had received anti-IL-4 antibody. The anti-IL-4-treated mice eventually
developed progressive infection, although the course ofdisease continued to be delayed
even at 8 wk . Treatment with an mAb against IFN-y of the same isotype had a min-
imal effect on the course ofinfection (slight exacerbation), consistent with the limited
amounts of IFN-y produced by these mice. Comparable results were obtained in
three separate experiments investigating the effects of anti-IL-4 administration on
the course of Leishmania infection .
Discussion
Previous studies have documented that L3T4+ lymphocytes taken from BALB/c
mice during progressive infection or after subcutaneous immunization with L. major
can adversely influence the course ofdiseasewhen transferred into recipient animals
(36, 37) . Conversely, L3T4+ lymphocytes taken from BALB/c mice that have re-
covered from Leishmania infection after prior immunologic manipulations, such
as thymectomy or sublethal irradiation, confer immunity on recipient mice (3, 37) .
We and others have previously shown that the numbers of L3T4+ cells within the
FIGURE 3 .
￿
Effect ofanti-IL-4 on thecourse ofleishmaniasis. Groups offour BALB/c mice were
infected with L . major in the hind footpads and the size of the lesions measured at 0, 1, 5, and
8 wk after no therapy (O) or weekly intraperitoneal injections of anti-IL-4 (O) or anti-
IFN-y(®) mAb . Mean and SD of the measurements are shown . Numbers in parentheses at
the top of the bars indicates the percentage of lesions that were ulcerated in each group .66
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TABLE Il
Tissue Amastigotes in BALBIc Mice Treated with Anti-IL-4 or
Anti-IFN-y During Leishmania Infection
Groups ofthree BALB/c mice were either untreated (control) or received week-
ly intraperitoneal injections of anti-IL-4 or anti-IFN-y mAbs after infection with
L. major. At 5 and 8 wk the footpads and popliteal lymph nodes draining the
lesions were harvested, minced, and diluted before in vitro culture for 3 d. Num-
bers indicate final dilutions of tissue yielding viable parasites.
lymph nodes and spleens of infected BALB/c mice are greater than or comparable
with those in healer strains of mice by 6-8 wk of infection (12-14) . As shown here,
however, lymphoid tissues from healer C57BL/6 mice or from BALB/c mice pretreated
with anti-L3T4 antibody contain message for IFN-y in vivo, whereas lymphoid tissues
from BALB/c mice with progressive infection contain message for IL-4, but little
for IFN-y. These results are most consistent with the hypothesis that the expansion
of L3T4+ cells during the resolution of leishmaniasis reflects preferential activation
of a different subset of L3T4+ cells than those activated during progressive infec-
tion . The disparate expression of IFN-y and IL-4 suggests that these subsets are the
in vivo correlates of the recently described subsets of murine L3T4+ T cell clones
(15).
The description oftwo subsets ofmurine Th clones, designated Thl and Th2 based
on their profiles of secreted lymphokines (15, 19), was followed by reports documenting
the presence and activation of both subsets after antigenic stimulation in vivo (16,
17). Thl cells preferentially secrete IFN-y and IL-2 (15, 19), and have been shown
to mediate delayed-type hypersensitivity (18) . Th2 cells preferentially secrete IL-4
and IL-5 in response to mitogenic or antigenic stimulation (19). Although IL-2 will
also support growth of Th2 cells, IL-4 acts as an autocrine growth factor in the pres-
ence of IL-1 (33, 38). By analogy with studies using cloned T cells (33, 38), the produc-
tion ofboth IL-4 and IL-1 message in the lymphoid organs of mice with progressive
Leishmania infection, as shown here, would presumably favor expansion ofTh2 cells.
Although the presence of IL-4 mRNA provides only indirect evidence for Th2 cell
activation, data from Th2 clones suggests that IL-4 is transcriptionally regulated
in response to activation stimuli (19).
Besides its activity as a T cell growth factor for Th2 cells, IL-4 has major B cell
growth and maturational activities (39, 40), and has been identified as an Ig switch
factor for IgG1 and IgE production (41). Marked hypergammaglobulinemia is char-
acteristic ofvisceral leishmaniasis, and would be consistent with the sustained produc-
tion of B cell stimulatory factors during the course of disease. Importantly, the pro-
Tissue
Dilution of tissue yielding
5 wk
viable leishmania
8 wk
Footpads
Control 10l >los
Anti-IL-4 102 106
Anti-IFN-y 106 >10s
Lymph nodes
Control l04 106
Anti-IL-4 10 ; l05
Anti-IFN-y 10' >lolHEINZEL ET AL.
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nounced elevations ofserumIgEthat were measured in BALB/c mice with progressive
leishmaniasis provide furtherevidence forthe functional activation ofTh2 cells. The
IgE levels were compatable with those accompanying infection with the intestinal
nematode Nippostrongylus brasiliensis (35). As in the studies reported here in leish-
maniasis, elevated IgE levels in Nippostrongylusinfectioncould be completely sup-
pressed with anti-IL-4 antibody (35).
The ability of prior anti-L3T4 antibody treatment to confer a healer phenotype
on susceptible BALB/c mice was associated both with the disappearance of mRNA
for IL-4, marked attenuation of the IgE rêsponse, and the appearance of mRNA
for IFN-y. These findings are consistent with activation of Thl, as opposed to Th2,
cells, and suggest that immunologic manipulations such as anti-L3T4 treatment or
sublethal irradiation must preferentially affect Th2 cell populations, perhaps due
to differences in the repopulation kinetics of these two L3T4+ T cell subsets after
their transient depletion. Despite the association of IL-2 secretion with Thl clones
(15), there was little relationship between the levels of IL-2 mRNA expression and
theoutcome of Leishmania infection. At late time periods (8 wk), IL-2 mRNA was
expressed at approximately twofold greater levels in healing mice (Fig. 2). Our pre-
liminary experiments utilizing cells enriched after complement-mediated antibody
lysis indicate that significant amounts of the IL-2 mRNA in nonhealing mice are
associated with Lyt-2' cells (unpublished observations). Evidence from Lyt-2'
depleted mice (42) and nude mice selectively reconstituted with either L3T4' or
Lyt-2' cells (4) suggests that Lyt-2' cells play at best a minor role in control of
Leishmania.
The association of IFN-y expression with healing has been shown in both murine
(7) and human (8, 9) leishmaniasis. Leishmania exist as obligate Ínftmacrophage
amastigotes in the mammalian host. Activation of macroplhdges is required for the
elimination of the organism in vitro, and IFN-y has beéh identified as the major
macrophage-activating factor mediatingdefense against Leishmania (10, 11). In the
kinetic experimentsdescribedhere, susceptible BALB/c mice did show evidence for
IFN-y production in the spleen during early infection, although message for this
lymphokine disappearedby thetime that visceral dissemination had occurred. IFN-y
mRNA was not present in the cells taken from the draining lymph nodes. The dis-
appearance of message from the spleen during the progression of disease is consis-
tent with theappearance ofa suppressor influence during infection. Data presented
here suggest that some of this influence may be mediated by IL-4.
Because ofthepleiotropic effects ofIL-4 on theimmune system, we administered
neutralizing anti-IL-4 antibody to infected BALB/c mice to establish whether ac-
tivities mediated by this lymphokine might be causally related to the progression
ofinfection. As demonstrated, anti-IL-4 therapysignificantly attenuated the progres-
sion of leishmaniasis as assessed both by the size of the local lesion and the numbers
of tissue parasites. The treated mice did eventually develop progressive disease as
evidenced by the increase in tissue parasites at 8 wk. This may have been related
to the developmentofantibodies to the rat mAb 11B11 as documented using .A capture-
sandwich ELISA to detect the presence of anti-rat antibodies (data not shown).
The mechanisms by which IL-4 might exacerbate Lei§hmáhia infection are un-
known. We presume that neutralization of IL-4 selectively interferes with Th2 cell
expansion and subsequent Th2-mediated suppression, although this is difficult to68
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prove in the absence of an understanding of the mechanisms for the latter process.
Because B cell depletion by administration of anti-u antibody before infection also
ameliorates subsequent disease (43), it is possible that anti-IL-4 interrupts critical
B cell circuits important for disease progression. Since passive transfer of antibody
has no effect on the course of disease (44), this putative B cell effect would be inde-
pendent of antibody. Additionally, IL-4 might directly interfere with macrophage
activation by IFN-y . Although IL-4 has some macrophage-activating capacities of
its own, including stimulation of class 11 antigen expression (45) and up-regulation
of CR3 (46), a macrophage receptor for Leishmania (47, 48), it cannot alone acti-
vate macrophages to resist parasitization by Leishmania (49). Previous studies have
documented that administration of IFN-y can ameliorate the course of Leishmania
infection in mice (50). Although IFN-y can directly activate macrophages to kill the
organism (7, 10, 11), it is possible that some of the beneficial effects are due to the
capacity of IFN-y to inhibit directly many of the effects of IL-4 (39, 51, 52), including
clonal expansion of Th2 cells (53). A combination of IFN-y and anti-IL-4 might
have major immunomodulatory effects on the course of Leishmania infection.
The data presented here suggest that progression of murine leishmaniasis occurs
with preferential activation of Th2 L3T4+ lymphocytes as demonstrated by tissue
expression of IL-4 and profound elevations of serum IgE. In contrast, resolution
of infection occurs with preferential activation of Thl L3T4+ lymphocytes as
demonstrated by tissue expression of IFN-y, a lymphokine known to stimulate eradi-
cation of intracellular Leishmania by infected macrophages, and by the acquisition
of delayed-type hypersensitivity responses to Leishmania antigens. These findings
suggest that the host response to infection with Leishmania, as assessed by the im-
munologic bias towards Thl or Th2 L3T4+ T cell activation, determines whether
infection is contained or allowed to progress. These data would predict that Leish-
mania antigens that preferentially stimulate Thl cells would serve as effective vac-
cine candidates, whereas those that stimulate Th2 cells might not. Whether bias
among Th subsets occurs in other spectral infectious diseases, such as leprosy or
coccidiodomycosis, will be important areas for further investigation.
Summary
We purified poly(A)+ mRNA from the spleen and lymph nodes at designated
times after infection with Leishmania major in genetically susceptible BALB/c and
resistant C57BL/6 mice. The steady-state levels of IL-2, IFN-y, IL-4, and IL-lß
mRNA were determined using Northern hybridizations. IL-2 mRNA levels in the
infected organs of BALB/c and C57BL/6 mice were comparable after infection, but
IFN-y and IL-4 mRNA levels were reciprocally expressed. Levels of IFN-y mRNA
in C57BL/6 draining nodes and spleen were significantly greater than in BALB/c
mice except at 4 and 6 wk of infection, when splenic IFN-y mRNA levels were tran-
siently comparable. In contrast, IL-4 mRNA was apparent only in BALB/c and not
in C57BL/6 nodes and spleen. Tissue levels ofIL-lß mRNA were 10-20-fold greater
in BALB/c mice. BALB/c mice were pretreated with GK1.5 mAb, a manipulation
that promotes healing of subsequent infection by transiently depleting L3T4+ cells.
At 8 wk of infection, by which time lymphoid organs were repopulated with L3T4+
cells, GK1 .5-pretreated BALB/c mice produced IFN-y, but not IL-4 message. Serum
levels of IgE were markedly elevated in infected BALB/c, but not in infected C57BL/6HEINZEL ET AL.
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or GK1.5-pretreated BALE/c mice, consistent with in vivo biologic activity of IL-4
in nonhealing mice. Treatment of infected BALB/c mice with neutralizing anti-IL-4
antibody abolished the elevation of serum IgE and significantly attenuated the progres-
sion of disease as assessed by size and ulceration of the lesion, and by reduction
in the number of tissue parasites.
Both protective and deleterious responses to Leishmania infection have previously
been shown to be L3T4+ cell dependent. Our findings are consistent with the
differential expansion of protective, IFN-y-producing Thl cells in healing mice, and
the expansion of deleterious, IL-4-producing Th2 cells in nonhealing mice. The in-
verse relationship ofIFN--f and IL-4 gene expression during leishmaniasis may un-
derlie the divergence of cellular and humoral immunity that occurs during chronic
infection with Leishmania and possibly other intracellular parasites.
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